Clinical added value of MRI over CT in patients scheduled for local colorectal liver metastases therapy
Recruiting
- Conditions
- Patients with colorectal liver metastases
- Registration Number
- NL-OMON27903
- Lead Sponsor
- KWF Kankerbestrijding
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 298
Inclusion Criteria
1. Histologically proof of colorectal cancer.
2. Patients with primary or recurrent CRLM who are considered candidates for curative surgery, thermal ablation, or
a combination of curative surgery and per-operative thermal ablation determined by the
multidisciplinary team (MDT) based on CT chest/abdomen.
3. No contraindications for liver surgery or thermal ablation.
4. Written informed consent.
Exclusion Criteria
1. Extrahepatic metastases on CT chest/abdomen that make curative treatment impossible.
2. Unresectable primary tumor, or resectable primary tumor requiring immediate surgery.
3. Patients with contra-indications for liver-MRI.
4. Previous inclusion in this study.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Additional CS-CRLM on liver-MRI
- Secondary Outcome Measures
Name Time Method 1. Develop a liver-MRI clinical prediction rule for specific subgroups<br>2. Evaluate total costs of performing liver-MRI